This systematic review assessed the effectiveness of oral versus parenteral vitamin B12 for treating vitamin B12 deficiency. The review identified 3 randomized controlled trials that met the inclusion criteria. The evidence from these trials shows that high daily doses of oral vitamin B12 (1000 μg) are as or more effective at producing hematological and neurological responses as parenteral administration. Lower doses of oral vitamin B12 (50 μg daily) also produce a hematological response compared to placebo but may not produce a significant neurological response. Very low doses of oral vitamin B12 (10 μg) do not produce significant hematological or neurological responses compared to placebo.